SCARNA11

Across TCGA pan-cancer cohorts, SCARNA11 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of SCARNA11’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where SCARNA11 RNA is repressed in tumor relative to normal tissue. In most cancer types SCARNA11 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

THCA, UCEC, and LUAD are the cancer types where SCARNA11 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SCARNA11 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	All	All	−0.113	.001	4	view →
UCEC	All	II,III,IV	+0.497	.019	2	view →
LUAD	Female	II,III,IV	+0.253	.006	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

SCARNA11–THCA

Open the THCA breakdown →